Stock ORX OREXO AB
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Orexo AB

Equities

ORX

SE0000736415

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:49 2024-04-26 am EDT 		5-day change 1st Jan Change
16.54 SEK -2.71% Intraday chart for Orexo AB +0.12% +6.99%
Apr. 17 Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment MT
Apr. 17 Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ORX Stock
  4. Revisions Orexo AB